Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.34 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7660873 | 0.83 | HTT (0.49) | HTTCXCR4PDCD1CD274RAB9A | |
| SCHEMBL7104686 | 0.82 | CYP1A2 (0.33) | CD274CYP1A2 | |
| SCHEMBL27113646 | 0.72 | EPHX2 (0.32) | CXCR4RAB9A | |
| SCHEMBL7107275 | 0.72 | LATS1 (0.33) | — | |
| SCHEMBL7655607 | 0.72 | NPSR1 (0.47) | CXCR4CD274CYP1A2 | |
| SCHEMBL7655866 | 0.72 | HTT (0.34) | HTTPDCD1CD274KMT2A | |
| SCHEMBL6132599 | 0.71 | HTT (0.50) | HTTRAB9APOLBALDH1A1CYP2D6 | |
| SCHEMBL16476543 | 0.69 | HTT (0.67) | HTTPDCD1CD274RAB9ACYP1A2 | |
| SCHEMBL23199259 | 0.68 | PIK3CD (0.41) | CXCR4CD274RAB9ACYP1A2POLB | |
| SCHEMBL28769415 | 0.68 | ESR1 (0.46) | KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6399613-B1 | N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES | AVENTIS PHARMA S.A. (FR) | 2002-06-04 | — | — | US | claimed |
| US-6399613-B1 | N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES | AVENTIS PHARMA S.A. (FR) | 2002-06-04 | — | — | US | disclosed |